Does GLEEVEC Cause Second primary malignancy? 10 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 10 reports of Second primary malignancy have been filed in association with GLEEVEC. This represents 3.8% of all adverse event reports for GLEEVEC.
10
Reports of Second primary malignancy with GLEEVEC
3.8%
of all GLEEVEC reports
1
Deaths
2
Hospitalizations
How Dangerous Is Second primary malignancy From GLEEVEC?
Of the 10 reports, 1 (10.0%) resulted in death, 2 (20.0%) required hospitalization.
Is Second primary malignancy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for GLEEVEC. However, 10 reports have been filed with the FAERS database.
What Other Side Effects Does GLEEVEC Cause?
Death (72)
Nausea (26)
Diarrhoea (24)
Fatigue (23)
Vomiting (23)
Fall (20)
Muscle spasms (18)
Asthenia (15)
Malaise (15)
Rash (14)
What Other Drugs Cause Second primary malignancy?
CYCLOPHOSPHAMIDE (1,247)
DOXORUBICIN (1,151)
VINCRISTINE (908)
IMATINIB (763)
PALBOCICLIB (658)
RITUXIMAB (646)
RUXOLITINIB (611)
ETOPOSIDE (573)
PREDNISONE (517)
OCTREOTIDE (496)
Which GLEEVEC Alternatives Have Lower Second primary malignancy Risk?
GLEEVEC vs GLICLAZIDE
GLEEVEC vs GLIMEPIRIDE
GLEEVEC vs GLIMEPIRIDE\ROSIGLITAZONE
GLEEVEC vs GLIPIZIDE
GLEEVEC vs GLIVEC